Y Intercept (Hong Kong) LTD Mirati Therapeutics, Inc. Transaction History

Y Intercept (Hong Kong) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $372,474 - $500,231	-2,819 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$144.0 - $179.73 $405,936 - $506,658	2,819 New	2,819 $455,000
Q2 2021 Aug 12, 2021	BUY	$144.0 - $179.73 $0 - $0	0 New	0 $455,000
Q1 2021 May 12, 2021	SELL	$158.92 - $221.61 $203,417 - $283,660	-1,280 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$162.05 - $240.27 $207,424 - $307,545	1,280 New	1,280 $281,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.